Patents by Inventor Robert Peter Erickson

Robert Peter Erickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975274
    Abstract: The present invention relates to a spray dried plasma composition having one or more of the following characteristics: when reconstituted, largely amorphous and has no cholesterol crystals; when reconstituted, the number of large particulates is reduced; has low residual moisture; reconstitutes rapidly in under four minutes; highly stable when stored under refrigeration, at room temperature or at elevated temperatures and allows for storage for longer periods of time; when reconstituted, exhibits recovery of the most fragile of proteins, including von Willebrand's factor; when reconstituted with Sterile Water for Injection (SWFI), reconstituted plasma is at a pH that is near normal plasma pH, and does so without treatment or storage in CO2 or other pH adjustment; and when reconstituted, has reduced complement activation (C5A, C3A).
    Type: Grant
    Filed: September 15, 2022
    Date of Patent: May 7, 2024
    Assignee: Velico Medical, Inc.
    Inventors: Qiyong Peter Liu, Herman E. Snyder, Kyle D. Erickson, Evan P. Ordway, William J. Merritt, Richard Meehan, Robert R. Andrews, Clair Strohl, Jihae Sohn, Mark A. Popovsky, Lisa A. Buckley
  • Publication number: 20240109000
    Abstract: The present invention relates to a spray dried plasma composition having one or more of the following characteristics: when reconstituted, largely amorphous and has no cholesterol crystals; when reconstituted, the number of large particulates is reduced; has low residual moisture; reconstitutes rapidly in under four minutes; highly stable when stored under refrigeration, at room temperature or at elevated temperatures and allows for storage for longer periods of time; when reconstituted, exhibits recovery of the most fragile of proteins, including von Willebrand's factor; when reconstituted with Sterile Water for Injection (SWFI), reconstituted plasma is at a pH that is near normal plasma pH, and does so without treatment or storage in CO2 or other pH adjustment; and when reconstituted, has reduced complement activation (C5A, C3A).
    Type: Application
    Filed: September 15, 2022
    Publication date: April 4, 2024
    Applicant: Velico Medical, Inc.
    Inventors: Qiyong Peter Liu, Herman E. Snyder, Kyle D. Erickson, Evan P. Ordway, William J. Merritt, Richard Meehan, Robert R. Andrews, Clair Strohl, Jihae Sohn
  • Patent number: 9406188
    Abstract: Methods and apparatus for preventing near-concurrent wins in a progressive gaming system controlled by Jackpot Controller are disclosed. A VLT player may send a “win” combination to the Jackpot Controller to determine whether the “win” awards the accumulating progressive jackpot. The Jackpot Controller may evaluate the “win” message. If the “win” message is valid, the “win” of the accumulating progressive jackpot may be confirmed. Other VLTs may be blocked from submitting “win” messages for that same progressive jackpot. The VLT may then distribute the proceeds to the player. The Jackpot Controller may initiate other progressive jackpot status communications to insure against a loss of data should an interruption event occur. Individual VLTs may initiate status messages to the Jackpot Controller should they remain inactive for a predetermined period.
    Type: Grant
    Filed: October 3, 2005
    Date of Patent: August 2, 2016
    Assignee: GTECH CANADA ULC
    Inventor: Robert Peter Erickson